Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.58 |
| ▸ | GSR | P00390 | 1/20 | 0.54 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29894486 | 0.98 | FOLH1 (0.59) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL29390540 | 0.98 | FOLH1 (0.59) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL29396372 | 0.96 | FOLH1 (0.52) | FOLH1GSRRNPEPCPB2MMP2 | |
| Glycine SCHEMBL15676612 | 0.92 | FOLH1 (0.59) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL29520684 | 0.90 | FOLH1 (0.53) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL28266171 | 0.88 | FOLH1 (0.56) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL30901213 | 0.88 | SLC6A5 (0.54) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL29511950 | 0.88 | FOLH1 (0.75) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL29529476 | 0.88 | SLC6A5 (0.54) | FOLH1GSRRNPEPCPB2MMP2 | |
| SCHEMBL296013 | 0.87 | FOLH1 (0.50) | FOLH1GSRRNPEPCPB2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4496488-A2 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | Cedars-Sinai Medical Center (US) | 2025-01-29 | — | — | EP | claimed |
| WO-2023183247-A2 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | CEDARS-SINAI MEDICAL CENTER (US) | 2023-09-28 | — | — | WO | claimed |
| EP-4496488-A2 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | Cedars-Sinai Medical Center (US) | 2025-01-29 | — | — | EP | disclosed |
| WO-2023183247-A2 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | CEDARS-SINAI MEDICAL CENTER (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-4163383-A1 | MICROBIAL PRODUCTION OF FATTY AMINES | Genomatica, Inc. (US) | 2023-04-12 | — | — | EP | disclosed |
| WO-2023044455-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2022109294-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2022-05-27 | — | — | WO | disclosed |